Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziprasidone in First-episode Schizophrenia Spectrum Disorder
NCT01157559Phase 4Completed
- Sponsor
- Jeonbuk National University Hospital
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ziprasidone in schizophrenia, schizophreniform disorder and schizoaffective disorder, sponsored by Jeonbuk National University Hospital. Primary endpoint: Symptoms assessment by objective rating scales at 8 weeks. Status: completed.
02
Drugs
ziprasidone
03
Conditions
schizophreniaschizophreniform disorderschizoaffective disorder
Beyond the preview
Go deeper on NCT01157559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01157559.